Overview

• Cancer 360 centralizes fragmented cancer patient data into a single digital platform, streamlining diagnosis and treatment pathways for millions of patients.
• Pilots at Royal United Hospitals Bath and Chelsea and Westminster Hospital demonstrated significant improvements, with 28-day diagnosis rates rising from 71.5% to 84.7% between 2022 and 2024.
• The technology, part of the NHS Federated Data Platform, reduces administrative burdens on clinicians, enabling them to focus more on patient care.
• While adoption remains voluntary, NHS trusts struggling to meet the 62-day treatment target may be encouraged to implement Cancer 360 to improve performance.
• Backed by £2 billion in government funding, the rollout is a key component of broader NHS modernization efforts, including a forthcoming National Cancer Plan.